Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial

URL

https://jamanetwork.com/journals/jama/fullarticle/2773108

Authors

Eric J. Lenze, Caline Mattar, Charles F. Zorumski, Angela Stevens, Julie Schweiger, Ginger E. Nicol, J. Philip Miller, Lei Yang, Michael Yingling, Michael S. Avidan, and Angela M. Reiersen

Published Date

November 12, 2020

Publication

JAMA (Journal of the American Medical Association)

Organization

Washington University in St Louis

Medium

document

Topics

COVID-19,fluvoxamine,medical treatments,pharmaceuticals